Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blood Volume Monitoring Via Critline in Volume Overload: Hospitalization and Readmission

NCT07866872 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT07866872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07866872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blood Volume Monitoring Via Critline in Volume Overload: Hospitalization and Readmission
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Enrolling by invitation
Start date
June 17, 2026
Completion date
June 30, 2027
Enrollment
400 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease (esrd), volume overload